IAVI in the News - 2017
Four big insights into HIV/AIDS that provide hope of finding a vaccine: Thumbi Ndung'u describes the cutting-edge research African scientists are engaged in toward an HIV vaccine. The Citizen
Working alongside a number of partner organizations, including IAVI, Janssen continues to make dramatic improvements for patients with HIV. Pharmafile
To address the challenges of providing more people with access to antiretroviral therapy in India, IAVI along with the Centers for Disease Control and Prevention came together in the national capital on Friday to discuss ways to accelerate HIV treatment prevention. “Globally, innovative programmes have been launched to tackle infectious diseases. These programmes must be integrated to address the problem, and countries across the world must develop end-to-end research capability which will, in turn, accelerate outcomes,” said Rajat Goyal, India Country Director of IAVI, in eHealth.
Thumbi Ndung'u, Scientific Director of the HIV Pathogenesis Programme (HPP) at the Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, which is one of IAVI's partners in South Africa, has been awarded a gold medal for his contributions to HIV and TB research by the 2017 South African Medical Research Council. The awards are among South Africa's most prestigious. Gold medals are awarded annually to established senior scientists who have made key contributions that have had an impact on the health of people. Africa Health Research Institute